Key Highlights

  • ClearVue Technologies (ASX: CPV) appointed Professor Rebecca Yang as an independent non-executive director, effective 16 July 2026.
  • Yang is a University of Melbourne professor and Doreen Thomas Fellow whose research centres on building-integrated photovoltaics and net-zero buildings.
  • The appointment follows a June 2026 placement raising roughly $4.9 million at $0.115 per share, plus a share purchase plan of up to $1 million.
  • ClearVue was selected to supply solar glass for Canva's Sydney headquarters and has rolled out its higher-output Gen3 solar vision glass.
  • The company remains pre-profit, so the board addition must ultimately support repeat orders and positive cash flow.

ClearVue Technologies (ASX: CPV) strengthened its board on 16 July 2026 with the appointment of Professor Rebecca Yang as an independent non-executive director. For the West Perth-based solar-glass developer, the recruitment adds recognised domain expertise at the top of the organisation as it pursues commercial orders across Australia, Europe and North America.

About the Appointment

Yang is a professor and Doreen Thomas Fellow at the University of Melbourne, where her research spans building-integrated photovoltaics (BIPV), net-zero buildings, digital twins and renewable energy integration into the built environment. Her academic focus sits almost exactly on top of ClearVue's commercial ambition: turning windows, façades and skylights into electricity-generating surfaces. Chair Theresa Smits said Yang's decision to join reflects confidence in the company's technology and strategy, while Yang herself described her interest in ClearVue's push to advance BIPV from research into real-world commercial applications.

A director with deep domain fluency can interrogate management's technical claims with more precision than an outsider and can connect the company to academic networks, industry consortia and policy discussions that shape BIPV standards and incentives. That said, the appointment is an advisory and oversight role, not a hands-on operational one. Its value will show up over time in the quality of strategic decisions, not in any single announcement.

About ClearVue Technologies

ClearVue develops and licenses transparent solar technology embedded into glazing and building materials. Its product range includes solar vision glass, spandrels, cladding, skylights, balustrades and horticultural glass. The company trades on the ASX as CPV and on the US OTCQX market as CVUEF. In September 2025 it unveiled Gen3 solar vision glass with materially higher energy output than earlier versions. More recently, ClearVue was selected to supply its product for Canva's Sydney headquarters, a high-profile reference project that can help de-risk the technology in the eyes of other developers. European certification has also opened a route into EU markets.

The harder reality is that BIPV has been a "promising" category for many years. Sales cycles for building materials are long, running through architects, builders, certifiers and property owners. ClearVue's task is to convert technical progress and marquee project wins into a repeatable, cash-generative business — and the board is being assembled to help execute on that challenge.

Recent Capital Raise

In late June 2026, ClearVue launched a placement of approximately 42.8 million new shares at $0.115 each, raising roughly $4.9 million before costs, with one free attaching option for every placement share. Options carry an exercise price of $0.115 and expire in September 2029. A share purchase plan of up to $1 million was offered to eligible retail holders on the same terms. The capital provides runway for commercial development but also dilutes existing holders, with attaching options representing further potential dilution if exercised. Until the company reaches self-sustaining cash flow, further raisings remain a live consideration.

What Investors May Watch Next

The most useful signals are practical and measurable. First, order flow — does the Canva selection convert to a delivered contract, and does it bring further agreements in its wake? Second, quarterly cash reports showing whether customer receipts are building and how long the latest raise will last. Third, product and certification progress that widens access to European and North American markets. Fourth, any commentary from the refreshed board on the commercial roadmap.

Risks

ClearVue is pre-profit and cash-consumptive. BIPV adoption is still in early stages and sales cycles are long. Competition from larger glass and solar manufacturers exists, and certification across multiple jurisdictions adds cost and time. Project announcements are not the same as delivered revenue, and timelines can slip. Further equity raisings to fund growth remain likely and would dilute existing shareholders.

This article is general information only and does not constitute personal financial advice. Investors should conduct their own research and consider their objectives, financial situation and needs.